Skip to main content

Permitted & Prohibited Claims

Misbranding under the FD&C Act

A device is misbranded if its labelling is false or misleading in any particular. Key misbranding violations include:

ViolationExample
False or misleading labellingClaiming efficacy not supported by evidence
Missing required informationOmitting adequate directions for use (without exemption)
Promoting cleared device for unapproved useAdvertising a wound dressing as cancer treatment
Using "FDA approved" for a 510(k)-cleared device (correct term is "FDA cleared")Cleared ≠ approved — this is misleading
Comparative claims without substantiation"Better than Brand X" without clinical evidence

Claims permitted for cleared devices

A 510(k)-cleared device may be promoted for its cleared indications for use. Labelling may include:

  • Efficacy claims supported by the 510(k) data
  • Comparative performance data (with substantiation)
  • Patient outcome data (if accurately representing study population)

The "intended use" risk of promotional claims

Making a promotional claim for a new use not covered by the existing clearance/approval creates a new intended use — and may require a new 510(k) or PMA before the claim can be made.

"FDA cleared" vs "FDA approved"

TermWhen correct to use
FDA clearedDevice went through 510(k) pathway
FDA approvedDevice went through PMA pathway
FDA authorisedMay refer to De Novo or EUA-authorised devices
FDA approved (for a cleared device)Incorrect — misbranding risk

Official resources

A promotional claim for a use not previously cleared or approved creates a new 'intended use' under FDA's definition (21 CFR § 860.3). Example: if a 510(k)-cleared wound dressing is promoted for 'diabetic foot ulcers' but was only cleared for 'minor cuts and abrasions,' this new indication requires submission of a new 510(k) or PMA before the claim can be made. Manufacturers should consult FDA's Determining Whether a Product is a Medical Device guidance to assess whether promotional language triggers new intended use.